Is CERo Therapeutics Holdings, Inc. (CERO) a Buy, Sell, or Hold?
CERo Therapeutics Holdings, Inc.
OTC:CERO
$0.012 USD
$0.0 (-7.69%)
- Volume
- 464.34K
- Average Volume
- 914.2K
- Market Capitalization
- $14.46K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $8.90
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.14
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
37
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
7
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$12.87M
CERO Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CERO Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Francois Eric | director | 2026-03-04 | A-Award | 0.055 | 2026-04-21 |
| Francois Eric | director: | 2026-02-13 | 0 | 2026-04-21 | |
| Rolfe Lindsey | director | 2026-01-07 | A-Award | 0.055 | 2026-01-09 |
| LAPORTE KATHLEEN | director | 2026-01-07 | A-Award | 0.055 | 2026-01-09 |
| Pierce Kristen | officer: Chief Development Officer | 2026-01-07 | A-Award | 0.055 | 2026-01-09 |
| Patel Shami | director | 2026-01-07 | A-Award | 0.055 | 2026-01-09 |
| ATWOOD BRIAN G | director | 2026-01-07 | A-Award | 0.055 | 2026-01-09 |
| Ehrlich Christopher B | director, officer: Chairman and CEO | 2026-01-07 | A-Award | 0.055 | 2026-01-09 |
| Byrnes Michael | director | 2026-01-07 | A-Award | 0.055 | 2026-01-09 |
| KUCHARCHUK ANDREW ALBERT | officer: Chief Financial Officer | 2026-01-07 | A-Award | 0.055 | 2026-01-09 |
| LAPORTE KATHLEEN | director | 2025-05-30 | A-Award | 0.4454 | 2025-06-02 |
| Byrnes Michael | director | 2025-05-30 | A-Award | 0.4454 | 2025-06-02 |
| Rolfe Lindsey | director | 2025-05-30 | A-Award | 0.4454 | 2025-06-02 |
| Patel Shami | director | 2025-05-30 | A-Award | 0.4454 | 2025-06-02 |
| Ehrlich Christopher B | director, officer: Chairman and CEO | 2025-05-30 | A-Award | 0.4454 | 2025-06-02 |
| ATWOOD BRIAN G | director | 2025-05-30 | A-Award | 0.4454 | 2025-06-02 |
| Pierce Kristen | officer: Chief Development Officer | 2025-05-30 | A-Award | 0.4454 | 2025-06-02 |
| KUCHARCHUK ANDREW ALBERT | officer: Chief Financial Officer | 2025-05-30 | A-Award | 0.4454 | 2025-06-02 |
| Pierce Kristen | officer: Chief Development Officer | 2024-10-01 | 10 | 2025-05-08 | |
| ATWOOD BRIAN G | director | 2025-03-31 | M-Exempt | 0.0001 | 2025-04-04 |
| ATWOOD BRIAN G | director | 2025-03-31 | M-Exempt | 0.0001 | 2025-04-04 |
| Ehrlich Christopher B | director, officer: Chairman and CEO | 2025-03-04 | A-Award | 1.43 | 2025-03-06 |
| Rolfe Lindsey | director | 2025-02-24 | A-Award | 0.1 | 2025-02-26 |
| Patel Shami | director | 2025-02-24 | A-Award | 0.0951 | 2025-02-26 |
| LAPORTE KATHLEEN | director | 2025-02-24 | A-Award | 0.1 | 2025-02-26 |
| Ehrlich Christopher B | director, officer: Chairman and CEO | 2025-02-24 | A-Award | 0.1 | 2025-02-26 |
| Byrnes Michael | director | 2025-02-24 | A-Award | 0.1 | 2025-02-26 |
| ATWOOD BRIAN G | director | 2025-02-24 | A-Award | 0.1 | 2025-02-26 |
| ATWOOD BRIAN G | director | 2025-02-07 | A-Award | 0.0001 | 2025-02-07 |
| ATWOOD BRIAN G | director | 2025-02-07 | A-Award | 1.96 | 2025-02-07 |
| ATWOOD BRIAN G | director | 2025-02-07 | A-Award | 0.0001 | 2025-02-07 |
| ATWOOD BRIAN G | director | 2025-02-07 | A-Award | 1.96 | 2025-02-07 |
| YK Bioventures Opportunities GP I, LLC | 10 percent owner | 2024-12-11 | S-Sale | 0.08 | 2024-12-13 |
| YK Bioventures Opportunities GP I, LLC | 10 percent owner | 2024-12-12 | S-Sale | 0.07 | 2024-12-13 |
| YK Bioventures Opportunities GP I, LLC | 10 percent owner | 2024-12-13 | S-Sale | 0.06 | 2024-12-13 |
| YK Bioventures Opportunities GP I, LLC | 10 percent owner | 2024-12-06 | S-Sale | 0.12 | 2024-12-10 |
| YK Bioventures Opportunities GP I, LLC | 10 percent owner | 2024-12-09 | S-Sale | 0.11 | 2024-12-10 |
| YK Bioventures Opportunities GP I, LLC | 10 percent owner | 2024-12-10 | S-Sale | 0.09 | 2024-12-10 |
| Ehrlich Christopher B | director, officer: Chairman and CEO | 2024-12-02 | A-Award | 0.1 | 2024-12-04 |
| Rolfe Lindsey | director | 2024-12-02 | A-Award | 0.1 | 2024-12-04 |
| LAPORTE KATHLEEN | director | 2024-12-02 | A-Award | 0.1 | 2024-12-04 |
| Byrnes Michael | director | 2024-12-02 | A-Award | 0.1 | 2024-12-04 |
| ATWOOD BRIAN G | director | 2024-12-02 | A-Award | 0.1 | 2024-12-04 |
| Patel Shami | director | 2024-12-02 | A-Award | 0.0951 | 2024-12-04 |
| SLOAN STUART M | 10 percent owner | 2024-09-25 | S-Sale | 0.1043 | 2024-11-20 |
| SLOAN STUART M | 10 percent owner | 2024-09-24 | 0 | 2024-11-20 | |
| YK Bioventures Opportunities GP I, LLC | 10 percent owner | 2024-10-10 | S-Sale | 0.1 | 2024-11-14 |
| YK Bioventures Opportunities GP I, LLC | 10 percent owner | 2024-09-26 | 0 | 2024-11-14 | |
| Patel Shami | director | 2024-10-11 | 0 | 2024-10-11 | |
| Patel Shami | director | 2024-10-11 | 0 | 2024-10-11 | |
| Patel Shami | director | 2024-03-15 | 11.5 | 2024-10-11 | |
| LAPORTE KATHLEEN | director | 2024-09-25 | M-Exempt | 1000 | 2024-10-02 |
| LAPORTE KATHLEEN | director | 2024-09-25 | M-Exempt | 0 | 2024-10-02 |
| Ehrlich Christopher B | director, officer: Interim Chairman and CEO | 2024-09-25 | M-Exempt | 1000 | 2024-10-02 |
| Ehrlich Christopher B | director, officer: Interim Chairman and CEO | 2024-09-25 | M-Exempt | 0 | 2024-10-02 |
| Ehrlich Christopher B | director, officer: Interim Chairman and CEO | 2024-09-30 | D-Return | 1.77 | 2024-10-02 |
| ATWOOD BRIAN G | director | 2024-09-25 | M-Exempt | 1000 | 2024-10-02 |
| ATWOOD BRIAN G | director | 2024-09-30 | D-Return | 1.77 | 2024-10-02 |
| ATWOOD BRIAN G | director | 2024-09-30 | D-Return | 5.28 | 2024-10-02 |
| ATWOOD BRIAN G | director | 2024-09-25 | M-Exempt | 0 | 2024-10-02 |
| KUCHARCHUK ANDREW ALBERT | officer: Chief Financial Officer | 2024-10-01 | A-Award | 0.1 | 2024-10-02 |
| Pierce Kristen | officer: Chief Development Officer | 2024-10-01 | A-Award | 0.1 | 2024-10-02 |
| KUCHARCHUK ANDREW ALBERT | officer | 2024-10-01 | 0 | 2024-10-02 | |
| Pierce Kristen | officer | 2024-10-01 | 0 | 2024-10-02 | |
| Carter Charles Ross | officer: Chief Financial Officer | 2024-06-28 | A-Award | 0.3 | 2024-07-01 |
| Rolfe Lindsey | director | 2024-03-25 | A-Award | 1.77 | 2024-03-27 |
| Rapaport Robyn | director | 2024-03-25 | A-Award | 1.77 | 2024-03-27 |
| LAPORTE KATHLEEN | director | 2024-03-25 | A-Award | 1.77 | 2024-03-27 |
| Ehrlich Christopher B | director | 2024-03-25 | A-Award | 1.77 | 2024-03-27 |
| Corey Daniel | director, officer: Chief Technical Officer | 2024-03-25 | A-Award | 1.77 | 2024-03-27 |
| Carter Charles Ross | officer: Chief Financial Officer | 2024-03-25 | A-Award | 1.77 | 2024-03-27 |
| Byrnes Michael | director | 2024-03-25 | A-Award | 1.77 | 2024-03-27 |
| ATWOOD BRIAN G | director, officer: Chief Executive Officer | 2024-03-25 | A-Award | 1.77 | 2024-03-27 |
| ATWOOD BRIAN G | director, officer: Chief Executive Officer | 2024-02-14 | A-Award | 5.28 | 2024-03-11 |
| Corey Daniel | director, officer: Chief Technical Officer | 2024-02-14 | 0 | 2024-02-26 | |
| Corey Daniel | director, officer: Chief Technical Officer | 2024-02-14 | 0 | 2024-02-26 | |
| Loewy Caroline M | director | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| Kosacz Barbara | director | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| Geffken Daniel E. | officer: Chief Financial Officer | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| Fisher Douglas Carl | officer: President | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| Fisher Douglas Carl | officer: President | 2024-02-14 | J-Other | 11.5 | 2024-02-16 |
| Fisher Douglas Carl | officer: President | 2024-02-14 | A-Award | 10 | 2024-02-16 |
| PHOENIX BIOTECH SPONSOR, LLC | 10 percent owner | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| PHOENIX BIOTECH SPONSOR, LLC | 10 percent owner | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| PHOENIX BIOTECH SPONSOR, LLC | 10 percent owner | 2024-02-14 | M-Exempt | 10 | 2024-02-16 |
| PHOENIX BIOTECH SPONSOR, LLC | 10 percent owner | 2024-02-14 | J-Other | 11.5 | 2024-02-16 |
| PHOENIX BIOTECH SPONSOR, LLC | 10 percent owner | 2024-02-14 | J-Other | 10 | 2024-02-16 |
| PHOENIX BIOTECH SPONSOR, LLC | 10 percent owner | 2024-02-14 | M-Exempt | 10 | 2024-02-16 |
| LAPORTE KATHLEEN | director | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| LAPORTE KATHLEEN | director | 2024-02-14 | A-Award | 10 | 2024-02-16 |
| Ehrlich Christopher B | director | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| Ehrlich Christopher B | director | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| Ehrlich Christopher B | director | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| Ehrlich Christopher B | director | 2024-02-14 | J-Other | 11.5 | 2024-02-16 |
| Ehrlich Christopher B | director | 2024-02-14 | J-Other | 0 | 2024-02-16 |
| Ehrlich Christopher B | director | 2024-02-14 | M-Exempt | 10 | 2024-02-16 |
| Ehrlich Christopher B | director | 2024-02-14 | J-Other | 10 | 2024-02-16 |
| Ehrlich Christopher B | director | 2024-02-14 | A-Award | 10 | 2024-02-16 |
| Ehrlich Christopher B | director | 2024-02-14 | M-Exempt | 10 | 2024-02-16 |
| Ehrlich Christopher B | director | 2024-02-14 | J-Other | 11.5 | 2024-02-16 |